← Open Payments lookup

ARDA KASACI: Open Payments

NPI 1043395338 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$546 in 20 payments from 8 companies in 2025. Trend: 2023 $653 · 2024 $465 · 2025 $546

Food & beverage: $534Education: $12
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.7$166
E.R. Squibb & Sons, L.L.C.3$162
Neurocrine BioSciences, Inc.4$91
Alkermes, Inc.2$33
Teva Pharmaceuticals USA, Inc.1$28
Axsome Therapeutics, Inc.1$24
Janssen Pharmaceuticals, Inc1$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18

Products named: COBENFY, FANAPT, INGREZZA, ARISTADA, UZEDY, Auvelity, INVEGA SUSTENNA, HETLIOZ.

Industry payments across DC — which companies pay providers there.